Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Natural Antioxidants in the Treatment of Multiple Sclerosis Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Natural Antioxidants in the Treatment of Multiple Sclerosis conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Natural Antioxidants in the Treatment of Multiple Sclerosis Clinical research trials and Natural Antioxidants in the Treatment of Multiple Sclerosis health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Natural Antioxidants in the Treatment of Multiple Sclerosis. Natural Antioxidants in the Treatment of Multiple Sclerosis Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Natural Antioxidants in the Treatment of Multiple Sclerosis clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Natural Antioxidants in the Treatment of Multiple Sclerosis condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "N" Clinical Trials Conditions > Natural Antioxidants in the Treatment of Multiple Sclerosis

Natural Antioxidants in the Treatment of Multiple Sclerosis



Natural Antioxidants in the Treatment of Multiple Sclerosis

For Condition: Multiple Sclerosis
Status: Completed
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to compare the effectiveness of three antioxidant regimens in treating the symptoms of multiple sclerosis (MS).
Details: Multiple sclerosis (MS) is an immune mediated disease of the central nervous system that affects over 350,000 Americans. T lymphocytes, macrophages and soluble mediators of inflammation cause demyelination and axonal injury in MS. Activated macrophages release nitric oxide and oxygen free radicals that cause demyelination and axonal injury in MS and experimental autoimmune encephalomyelitis (EAE). Natural antioxidants may favorably influence the course of MS by decreasing oxidative injury. Chronic relapsing EAE in mouse models is clinically and pathologically useful for testing potential therapies for MS. This study will assess three natural antioxidant regimens for their potential as treatments for MS: Ginkgo biloba, alpha-lipoic acid/essential fatty acids, and vitamin E/selenium. The effects of each regimen will be compared to determine which regimen appears most effective at suppressing EAE and decreasing markers of oxidative injury in patients with MS. As part of this study, two smaller trials will be conducted. A Phase I/II trial in patients with MS will determine if the selected antioxidant regimen can decrease disease activity as detected with gadolinium-enhanced magnetic resonance imaging. The results of this study will serve as the basis for a Phase III trial to assess the long term effectiveness of natural antioxidant therapy in MS.
Eligibility:
Study Type:  Interventional, Treatment, Randomized
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Exclusion Criteria: - Pregnant - Other significant health problems
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
Dr.Bourdette,  Principal Investigator,  VA Medical Center-Brooklyn

Oregon Health Sciences University
Portland,  Oregon,  97207
United States
 


Additional Information:
Study ID Numbers:  1 P50 AT00066-01P1;  1 P50 AT00066-01
Study Start Date: 
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00010842

Other Multiple Sclerosis Studies:
1. Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)

2. MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis

3. Safety and Efficacy study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis

4. Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients

5. Assessment of Patients with Multiple Sclerosis (MS)

Related Studies:

Other Multiple Sclerosis Clinical Trials
Other Oregon Clinical Trials
Other Portland Clinical Trials

Natural Antioxidants in the Treatment of Multiple Sclerosis
Modify your Search

  Other Multiple Sclerosis Clinical Trials
  Other Oregon Clinical Trials
  Other Portland Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103